Home > Boards > US Listed > Biotechs > Atossa Genetics, Inc. (ATOS)

Way to Early!! $$$ Anything under 10.00 is

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ALL-IN888 Member Profile
Member Level 
Followed By 655
Posts 35,369
Boards Moderated 0
Alias Born 08/09/10
160x600 placeholder
Atossa Genetics to Present September 10 at the 21st Annual Rodman and Renshaw Global Investment Conference GlobeNewswire Inc. - 9/6/2019 8:30:00 AM
Atossa Genetics Announces Completion of Enrollment and Dosing in Phase 1 Clinical Trial of New Proprietary Modified-Release O... GlobeNewswire Inc. - 9/3/2019 8:00:00 AM
Atossa Genetics Announces Second Quarter 2019 Financial Results and Provides Company Update GlobeNewswire Inc. - 8/13/2019 1:26:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2019 8:33:56 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2019 8:32:21 AM
Atossa Genetics CEO Steven Quay Gives Tedx Talk At University of Washington Regarding the the Relationship of Dense Breast Ti... GlobeNewswire Inc. - 7/30/2019 8:30:00 AM
Atossa Genetics Provides Information on FDA Expanded Access Policy and Requests GlobeNewswire Inc. - 7/17/2019 8:30:00 AM
Atossa Genetics Announces New Proprietary Modified-Release Oral Endoxifen Tablet; Phase 1 Clinical Trial Initiated GlobeNewswire Inc. - 7/11/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/27/2019 12:49:44 PM
Atossa Genetics’ Preliminary Phase 2 Study Achieves Primary Endpoint: Topical Endoxifen Rapidly Reduces Breast Density GlobeNewswire Inc. - 6/27/2019 8:00:00 AM
Atossa Genetics to Present at the 9th Annual LD Micro Invitational on June 4, 2019 GlobeNewswire Inc. - 5/30/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2019 4:32:45 PM
Atossa Genetics Announces First Quarter 2019 Financial Results and Provides Company Update GlobeNewswire Inc. - 5/13/2019 5:21:57 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2019 4:35:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/13/2019 4:32:57 PM
Atossa Genetics Provides Clinical Update at the 4th Annual Precision: Breast Cancer World R&D Summit GlobeNewswire Inc. - 4/25/2019 12:00:00 PM
Atossa Genetics to Present at the 4th Annual Precision: Breast Cancer World R&D Summit April 25, 2019 GlobeNewswire Inc. - 4/22/2019 8:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/12/2019 12:02:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/28/2019 4:34:52 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/28/2019 4:34:51 PM
Atossa Genetics Announces Year End 2018 Financial Results and Provides Company Update GlobeNewswire Inc. - 3/28/2019 4:30:00 PM
Atossa Genetics Announces Institutional Review Board Approval of Oral Endoxifen as Post-Mastectomy Treatment for a U.S. Breas... GlobeNewswire Inc. - 3/26/2019 8:30:00 AM
Atossa Genetics Announces Receipt of $10 Million GlobeNewswire Inc. - 3/18/2019 8:30:00 AM
Atossa Genetics Announces FDA Approval of Oral Endoxifen for “Expanded Access” as Post-Mastectomy Treatment for a U.S. Br... GlobeNewswire Inc. - 3/14/2019 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/8/2019 1:32:19 PM
ALL-IN888 Member Level  Thursday, 03/14/19 04:28:12 PM
Re: Dnatravel post# 1945
Post # of 2984 
Way to Early!! $$$ Anything under 10.00 is a Gift!

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist